Search

Your search keyword '"Alentorn, Agustí"' showing total 25 results
Start Over Author "Alentorn, Agustí"
25 results on '"Alentorn, Agustí"'

1. Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study

Author

Lesueur, Paul, Damaj, Gandhi, Hoang-Xuan, Khê, Roland, Virginie, Schmitt, Anna, Chinot, Olivier, Fabbro, Michel, Agapé, Philippe, Moluçon-Chabrot, Cécile, Chebrek, Safia, Alentorn, Agusti, Feuvret, Loic, Delgadillo, Daniel, Stefan, Dinu, Choquet, Sylvain, Nichelli, Lucia, Mokhtari, Karima, Mathon, Bertrand, Dureau, Sylvain, Soussain, Carole, and Houillier, Caroline

Published
2022
Full Text
View/download PDF

6. Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review

Author

Alentorn, Agustí, primary, Berzero, Giulia, additional, Alexopoulos, Harry, additional, Tzartos, John, additional, Botero, Germán Reyes, additional, Martínez, Andrea Morales, additional, Muñiz-Castrillo, Sergio, additional, Vogrig, Alberto, additional, Joubert, Bastien, additional, Jiménez, Francisco A. García, additional, Cabrera, Dagoberto, additional, Tobon, José Vladimir, additional, Delgado, Carolina, additional, Sandoval, Patricio, additional, Troncoso, Mónica, additional, Galleguillos, Lorna, additional, Giry, Marine, additional, Benazra, Marion, additional, Verdin, Isaias Hernández, additional, Dade, Maëlle, additional, Picard, Géraldine, additional, Rogemond, Véronique, additional, Weiss, Nicolas, additional, Dalakas, Marinos C., additional, Boëlle, Pierre-Yves, additional, Delattre, Jean-Yves, additional, Honnorat, Jérôme, additional, and Psimaras, Dimitri, additional

Published
2023
Full Text
View/download PDF

10. Pan-cancer landscape of AID-related mutations, composite mutations and its potential role in the ICI response

Author

Verdin, Isaias Hernández, primary, Akdemir, Kadir C., additional, Ramazzotti, Daniele, additional, Caravagna, Giulio, additional, Labreche, Karim, additional, Mokhtari, Karima, additional, Hoang-Xuan, Khê, additional, Peyre, Matthieu, additional, Bielle, Franck, additional, Touat, Mehdi, additional, Idbaih, Ahmed, additional, Duval, Alex, additional, Sanson, Marc, additional, and Alentorn, Agustí, additional

Published
2021
Full Text
View/download PDF

13. Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas

Author

Alentorn, Agustí, primary, Dehais, Caroline, additional, Ducray, François, additional, Carpentier, Catherine, additional, Mokhtari, Karima, additional, Figarella-Branger, Dominique, additional, Chinot, Olivier, additional, Cohen-Moyal, Elisabeth, additional, Ramirez, Carole, additional, Loiseau, Hugues, additional, Elouahdani-Hamdi, Selma, additional, Beauchesne, Patrick, additional, Langlois, Olivier, additional, Desenclos, Christine, additional, Guillamo, Jean-Sébastien, additional, Dam-Hieu, Phong, additional, Ghiringhelli, François, additional, Colin, Philippe, additional, Godard, Joel, additional, Parker, Fabrice, additional, Dhermain, Frédéric, additional, Carpentier, Antoine F., additional, Frenel, Jean-Sebastien, additional, Menei, Philippe, additional, Bauchet, Luc, additional, Faillot, Thierry, additional, Fesneau, Mélanie, additional, Fontaine, Denys, additional, Motuo-Fotso, Marie-Jeannette, additional, Vauleon, Elodie, additional, Gaultier, Claude, additional, Le Guerinel, Caroline, additional, Gueye, Edouard-Marcel, additional, Noel, Georges, additional, Desse, Nicolas, additional, Durando, Xavier, additional, Barrascout, Eduardo, additional, Wager, Michel, additional, Ricard, Damien, additional, Carpiuc, Ioana, additional, Delattre, Jean-Yves, additional, and Idbaih, Ahmed, additional

Published
2015
Full Text
View/download PDF

16. Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas

Author

Alentorn, Agustí, primary, van Thuijl, Hinke F., additional, Marie, Yannick, additional, Alshehhi, Hussa, additional, Carpentier, Catherine, additional, Boisselier, Blandine, additional, Laigle-Donadey, Florence, additional, Mokhtari, Karima, additional, Scheinin, Ilari, additional, Wesseling, Pieter, additional, Ylstra, Bauke, additional, Capelle, Laurent, additional, Hoang-Xuan, Khê, additional, Sanson, Marc, additional, Delattre, Jean-Yves, additional, Reijneveld, Jaap C., additional, and Idbaih, Ahmed, additional

Published
2013
Full Text
View/download PDF

25. Oligodendrogliomas: new insights from the genetics and perspectives.

Author

Alentorn A, Sanson M, and Idbaih A

Subjects
Animals, Brain Neoplasms classification, Brain Neoplasms enzymology, Chromosomes, Human, Pair 1 genetics, Chromosomes, Human, Pair 19 genetics, DNA Helicases genetics, DNA-Binding Proteins genetics, Genetic Association Studies, Humans, Isocitrate Dehydrogenase genetics, Oligodendroglioma classification, Oligodendroglioma enzymology, Point Mutation, RNA-Binding Proteins, Sequence Deletion, Brain Neoplasms genetics, Oligodendroglioma genetics
Abstract

Purpose of Review: Since the discovery, in 1994, of recurrent codeletion of chromosome regions 1p36/19q13 in oligodendrogliomas, genetics has accomplished significant advances improving our knowledge in biology of this tumor type and our clinical management of oligodendroglioma patients. Indeed, 1p36/19q13 has been shown successively to predict increased chemosensitivity and better prognosis, to be associated with frontal location in brain and classic oligodendroglioma morphology, to be mutually exclusive with high-level gene amplification, to be actually whole chromosome arms 1p/19q codeletion, to mediate a t(1;19)(q10;p10) and to be associated with IDH mutations. More recently, pivotal studies, using high-throughput approaches, have provided significant novel insights in the molecular oncogenesis of oligodendrogliomas., Recent Findings: Capicua homolog (Drosophila) (CIC) and Far Upstream element Binding Protein 1 (FUBP1) have been shown to be frequently mutated in 70 and 40% of 1p/19q codeleted oligodendrogliomas, respectively. The biological and clinical significance of these mutations remains unsettled. Additional recent studies have also demonstrated that 1p/19q codeleted oligodendrogliomas exhibit a proneural transcriptomic profile including overexpression of internexin alpha, a neuronal intermediate filament. Finally, 1p/19q codeleted and IDH-mutated tumors have been shown to be hypermethylated, suggesting a strong link between these both molecular alterations detected in the subgroup of oligodendrogliomas with better prognosis., Summary: Next-generation molecular biology technologies have recently identified recurrent CIC and FUBP1 point mutations in 1p/19q codeleted and IDH-mutated oligodendrogliomas. Their clinical and biological values are under investigation.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results